Diakron Pharmaceuticals Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Diakron Pharmaceuticals General Information

Description

Developer of cardiovascular drug. The company is engaged in drug discovery for cardiovascular related fields. It has development programs targeting clotting disorders, hypertension and diabetes.

Contact Information

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Primary Office
  • P.O. Box 748
  • Morris Plains, NJ 07950
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Diakron Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Diakron Pharmaceuticals‘s full profile, request access.

Request a free trial

Diakron Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Richard Chenot Chief Financial Officer
Robert Anderson Chief Marketing Officer
Srirama Rao Ph.D Chairman, Chief Scientific Officer & Co-Founder
Stephane Allard MD Chief Medical Officer
Martin Cearnal President & Chief Executive Officer
To view Diakron Pharmaceuticals’s complete executive team members history, request access »